Search - tctmd.com

Displaying 241 - 260 of 435

Sort: Relevancy | Date

Presentation NY Valves 2025

Intra-Procedural Management of Single Leaflet Device Attachment During Tricuspid TEER: A Complex Case of Successful Stabilization With Multiple TriClip Devices

Presenter: Radwan Alkhatib

June 25, 2025

Presentation NY Valves 2025

Transcatheter Mitral Valve Replacement Using Contemporary Dedicated Devices: A Systematic Review and Meta-Analysis

Presenter: Mark Zorman

June 25, 2025

Presentation NY Valves 2025

Device Choice Considerations

Presenter: Ryan K. Kaple

June 25, 2025

Presentation NY Valves 2025

Anatomic Considerations for Device Selection: Are Device v Device Trials Meaningful?

Presenter: Ole De Backer

June 25, 2025

Presentation NY Valves 2025

Terminology and Important Design Features of the M-TEER Devices

Presenter: Anita W. Asgar

June 25, 2025

Presentation NY Valves 2025

Efficacy of CEP Devices to Reduce Stroke during TAVR: Insights From the TVT Registry

Presenter: David J. Cohen

June 25, 2025

Presentation NY Valves 2025

Outcomes in Patients Discharged on OAC vs. DAPT After Left Atrial Appendage Occlusion Using a Fluoropolymer Coated Device: A Sub-analysis of the HEAL-LAA Post Approval Study

Presenter: Seun Alli

June 25, 2025

Presentation NY Valves 2025

Outcomes of Same-day vs. Delayed Discharge After LAAC Using a Fluoropolymer Coated Device: HEAL-LAA Post Approval Study Sub-analysis

Presenter: Jeremiah P. Depta

June 25, 2025

Presentation NY Valves 2025

BONAPART: A Novel Mechanical Leaflet Splitting Device

Presenter: Eberhard Grube

June 25, 2025

Presentation NY Valves 2025

Leave No Appendage Behind: Simultaneous Use of Two Watchman Devices to Occlude Bilobed Left Atrial Appendage

Presenter: Ashwin Mahesh

June 25, 2025

Presentation NY Valves 2025

Post-TTVR Function: Normal or Abnormal

Presenter: G. Burkhard Mackensen

June 25, 2025

Presentation NY Valves 2025

Optimizing Mitral TEER in FMR: Technical and Device Strategies

Presenter: Jörg Hausleiter

June 25, 2025

Presentation NY Valves 2025

How Do I Assess the Mechanism and Severity of MR After M-TEER?

Presenter: Federico M. Asch

June 25, 2025

Presentation NY Valves 2025

Prosthetic Aortic Valve Function: Normal or Abnormal

Presenter: Kyle R. Lehenbauer

June 25, 2025

Presentation NY Valves 2025

Structural Valve Dysfunction: Overview of Definitions

Presenter: Philippe Pibarot

June 25, 2025

Presentation NY Valves 2025

AI-Based Simulation to Predict Device Performance and Procedural Success in SHD Interventions

Presenter: Omar K. Khalique

June 25, 2025

News Daily News

Underexpanded Acurate Valves Come With Higher Stroke Risk, Study Confirms

Todd Neale

June 18, 2025

News Daily News

‘Sobering’ Adverse Event Rate With Evoque Seen in Real-world Use

Yael L. Maxwell

June 18, 2025

News Daily News

Valve Thrombosis in TTVR Not Uncommon: Meta-analysis

Caitlin E. Cox

June 17, 2025

News Daily News

Delays in STEMI Treatment Remain Common, Tied to Worse PCI Outcomes

Todd Neale

June 13, 2025

Advertisement

Intra-Procedural Management of Single Leaflet Device Attachment During Tricuspid TEER: A Complex Case of Successful Stabilization With Multiple TriClip Devices

Transcatheter Mitral Valve Replacement Using Contemporary Dedicated Devices: A Systematic Review and Meta-Analysis

Device Choice Considerations

Anatomic Considerations for Device Selection: Are Device v Device Trials Meaningful?

Terminology and Important Design Features of the M-TEER Devices

Efficacy of CEP Devices to Reduce Stroke during TAVR: Insights From the TVT Registry

Outcomes in Patients Discharged on OAC vs. DAPT After Left Atrial Appendage Occlusion Using a Fluoropolymer Coated Device: A Sub-analysis of the HEAL-LAA Post Approval Study

Outcomes of Same-day vs. Delayed Discharge After LAAC Using a Fluoropolymer Coated Device: HEAL-LAA Post Approval Study Sub-analysis

BONAPART: A Novel Mechanical Leaflet Splitting Device

Leave No Appendage Behind: Simultaneous Use of Two Watchman Devices to Occlude Bilobed Left Atrial Appendage

Post-TTVR Function: Normal or Abnormal

Optimizing Mitral TEER in FMR: Technical and Device Strategies

How Do I Assess the Mechanism and Severity of MR After M-TEER?

Prosthetic Aortic Valve Function: Normal or Abnormal

Structural Valve Dysfunction: Overview of Definitions

AI-Based Simulation to Predict Device Performance and Procedural Success in SHD Interventions

Underexpanded Acurate Valves Come With Higher Stroke Risk, Study Confirms

‘Sobering’ Adverse Event Rate With Evoque Seen in Real-world Use

Valve Thrombosis in TTVR Not Uncommon: Meta-analysis

Delays in STEMI Treatment Remain Common, Tied to Worse PCI Outcomes

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content